Epic Chain vs Injective — how do they compare? Epic Chain trades at Rp7,806 (market cap Rp260,25M, Rp282,37M 24h volume), while Injective trades at Rp93,269 (market cap Rp9,26T, Rp1,73T 24h volume). The key difference: Injective is far larger — about 35581.2× Epic Chain's market cap, and Epic Chain's supply is capped (33,6M / 33,6M EPIC (100%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Epic Chain for 10 Days and Injective for 36 Days on average.
| EPIC | INJ | |
|---|---|---|
Market Cap | Rp260,25M | Rp9,26T |
Volume (24h) | Rp282,37M | Rp1,73T |
Circulating Supply | 33,6M / 33,6M EPIC (100%) | 100M INJ |
Typical Hold Time | 10 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Epic Chain (EPIC) trades at Rp8,072 with a market cap of Rp269.34 million, showing a neutral overall technical signal. The asset has 100% circulating supply, indicating full token distribution, and a short average hold time of 10 days. Technical indicators present mixed signals, with moving averages bullish but oscillators neutral. Support and resistance levels are well-defined, with current price near the pivot point of Rp7,076. No recent protocol updates or major ecosystem developments were identified.
Overall outlook is neutral with limited upside momentum. Key opportunities include potential breakout above resistance levels if buying pressure increases. Major risks involve low liquidity, high volatility due to small market cap, and lack of recent development activity. Investors should monitor volume trends and any upcoming network updates closely.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Epic Chain (EPIC), the successor to Ethernity Chain (ERN), was approved by 97.1% of the community and now operates as an ETH Layer 2 blockchain. Focused on Real World Assets (RWAs) and entertainment, it integrates AI-driven security, DRM, and Web3 technology. With the entertainment market set to hit $3.5 trillion by 2030, Epic Chain enables global brands to bring franchises on-chain, already featuring icons like Messi, Shaq, and Muhammad Ali. Now, it expands into top entertainment franchises with improved scalability, security, and efficiency.
Read more on EPIC →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →